RBM15 and thyroid gland carcinoma: As shown in Fig. 3A, high expression of RBM15 (HR = 4.341, 95% CI = 1.328–14.192, P = 0.015), FTO (HR = 1.623, 95% CI = 1.021–2.580, P = 0.041) and KIAA1429 (HR = 1.925, 95% CI = 1.079–3.434, P = 0.026) had a poor overall survival in patients with thyroid carcinoma.